Selectis Health Announces Board & Executive Changes
Ticker: GBCS · Form: 8-K · Filed: Jul 11, 2024 · CIK: 727346
| Field | Detail |
|---|---|
| Company | Selectis Health, Inc. (GBCS) |
| Form Type | 8-K |
| Filed Date | Jul 11, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, executive-compensation, board-of-directors
TL;DR
Board shake-up and pay changes at Selectis Health.
AI Summary
Selectis Health, Inc. announced on June 30, 2024, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for its named executive officers.
Why It Matters
Changes in a company's leadership and executive compensation can signal shifts in strategy or financial health, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in directorship and executive compensation can indicate internal restructuring or strategic shifts that may carry inherent risks.
Key Players & Entities
- Selectis Health, Inc. (company) — Registrant
- June 30, 2024 (date) — Date of earliest event reported
- Utah (location) — State of incorporation
FAQ
What specific roles have been affected by the departure of officers and directors?
The filing indicates changes in directorship and executive roles, but does not specify the exact positions vacated or filled in this excerpt.
When did the reported changes in leadership and compensation take effect?
The earliest event reported is dated June 30, 2024.
What is the primary business of Selectis Health, Inc. according to the filing?
The filing lists Selectis Health, Inc. under the Standard Industrial Classification for Real Estate Investment Trusts [6798].
Has Selectis Health, Inc. undergone previous name changes?
Yes, the company was formerly known as Global Healthcare REIT, Inc. (name change effective October 4, 2013), Global Casinos Inc (name change effective April 13, 1995), and Morgro Chemical Co (name change effective July 3, 1992).
Where is Selectis Health, Inc. headquartered?
The company's business and mailing address is 8480 E. Orchard Road, Suite 4900, Greenwood Village, CO 80111.
Filing Stats: 359 words · 1 min read · ~1 pages · Grade level 11.6 · Accepted 2024-07-11 16:08:34
Filing Documents
- form8-k.htm (8-K) — 30KB
- 0001493152-24-026955.txt ( ) — 195KB
- gbcs-20240630.xsd (EX-101.SCH) — 3KB
- gbcs-20240630_lab.xml (EX-101.LAB) — 33KB
- gbcs-20240630_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2024 SELECTIS HEALTH, INC. (Exact Name of Registrant as Specified in its Charter) Utah 0-15415 87-0340206 (State or other jurisdiction of incorporation) Commission File Number (I.R.S. Employer Identification number) 8480 E. Orchard Road , Ste. 4900 , Greenwood Village , CO 80111 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (720) 680-0808 (Former name or former address, if changed since last report) Written communications pursuant to Rule 425 under the Securities Act Soliciting material pursuant to Rule 14a-12 under the Exchange Act Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Securities registered pursuant to Section 12(b) of the Act: Title of each Class Trading Symbol Name of each exchange on which registered N/A N/A N/A Indicate by check mark whether the registrant is an emerging growth company as dened in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised nancial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS, APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGES OF CERTAIN OFFICERS On June 24, 2024, Andrew Sink tendered his resignation as a member of the of the Selectis Health, Inc. (the "Company") Board of Directors, effective June 30, 2024. There are no immediate plans to fill the vacancy caused by Mr. Sink's resignation. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Selectis Health, Inc. (Registrant) Dated: July 11, 2024 /s/ Adam Desmond Adam Desmond, CEO